logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
陆

陆舜 (Shun Lü)

Shanghai Chest Hospital

78H-index
900Paper Count
3.7WCitation Count
Published Papers 231
Publication Date
logo
Real-world treatment pattern and clinical outcomes in Chinese NSCLC patients with KRAS G12C mutation
errBMC Cancer
IF3.4
err2026-07-30
err0
errOAAI
errLan Shen; Yibo Gao; Zhengbo Song; Qiming Wang; Qiaoxia Zhou; Yan Lei; Shun Lu; Ziming Li
errShare
errSave
AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥50%
errJournal of Thoracic Oncology
IF20.8
err2026-07-14
err0
PREAI
errMark A. Socinski; Martin Reck; Luis Paz-Ares; Makoto Nishio; Alexander I. Spira; Xinmin Yu; Tamar Melkadze; Aiping Zeng; Alejandro Martinez-Bueno; Xingya Li; Surein Arulananda; Yunxia Zuo; Sandra Chica-Duque; Wanjun Dai; Jincheng Zhou; Wei Tan; Shun Lu
errShare
errSave
Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC: The ACTIVE Trial
errJournal of Thoracic Oncology
IF20.8
err2026-06-24
err0
errOAAI
errZiming Li; Biao Yao; Chun Huang; Conghua Xie; Renhua Guo; Jueping Feng; Wenxiu Yao; Hongyan Huang; Yongsheng Li; Yueyin Pan; Shun Lu
errShare
errSave
Author Correction: A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice
errNature Microbiology
IF19.4
err2026-06-16
err0
PREAI
errHaiyan Zhou; Ruiming Sun; Xiaoqun Nie; Liliang Xia; Hui Dong; Yujie Liu; Shurui Hou; Wenyue Dong; Xiaokuan Zhu; Yaxian Yao; Guo-Ping Zhao; Shun Lu; Ying Wang; Chen Yang
errShare
errSave
Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study
errLung Cancer
IF4.4
err2026-06-06
err0
PREAI
errTerufumi Kato; Xiaorong Dong; Toshiaki Takahashi; Nopadol Soparattanapaisarn; Sarayut Lucien Geater; Chih-Liang Wang; Edurne Arriola; Fedor Moiseenko; Lucy Thompson; Ellie Grainger; Elena Armenteros-Monterroso; Azura Evans; Ana Bolanos; Suresh S. Ramalingam; Shun Lu
errShare
errSave
MYBL2 impedes cisplatin sensitivity through suppressing GSDME-mediated pyroptosis in lung adenocarcinoma.
errCell Death Discovery
IF7
err2026-06-02
err0
errOAAI
errTingting Lu; Jie Zhang; Wendi Xuzhang; Xiru Quan; Guangling Jie; Ziming Li; Shun Lu
errShare
errSave
TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with <i>EGFR</i> -mutated locally advanced or metastatic non-small cell lung cancer
errTherapeutic Advances in Medical Oncology
IF4.2
err2026-05-20
err0
PREAI
errShun Lu; Mariano Provencio Pulla; Eldsamira Mascarenhas; Junko Tanizaki; Hye Ryun Kim; Yinglei Liu; Shengmei Feng; Biao Zhang; Laurence Toms; James Chih-Hsin Yang; Sarah B. Goldberg
errShare
errSave
SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China
errJournal of Thoracic Oncology
IF20.8
err2026-04-06
err0
errOAAI
errShun Lu; Jian Fang; Yan Yu; Yun Fan; Xiaorong Dong; Ziping Wang; Qiming Wang; Jialei Wang; Jiuwei Cui; Hongming Pan; Qiong Wu; Chanjuan Lin; Li Zhang; Raymond Meng; Chang Liu; Xiayu Huang; Namrata S. Patil
errShare
errSave
Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort
errLung Cancer
IF4.4
err2026-02-23
err0
errOAAI
errXiaorong Dong; Hong Jian; Meijuan Huang; Shuanghu Yuan; Zhengfei Zhu; Lin Wu; Ming Chen; Nan Bi; Yi Pan; Yingyi Wang; Dongqing Lv; Elena Armenteros Monterroso; Xiangning Huang; Rui Mao; Wei Fu; Yi Zhao; Shun Lu
errShare
errSave
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis
errLung Cancer
IF4.4
err2026-02-04
err0
PREAI
errHidetoshi Hayashi; Byoung Chul Cho; Yu Jung Kim; Se-Hoon Lee; Pongwut Danchaivijitr; Adlinda Alip; Hailin Xiong; Soon-Hin How; Gee-Chen Chang; James Chih-Hsin Yang; Yuta Yamanaka; Mehmet Ali Nahit Şendur; Kumar Prabhash; Koichi Azuma; Alianu Akawung; Elizabeth Fennema; Xiaodan Tang; Sujay Shah; Seema Sethi; Shun Lu
errShare
errSave
Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer
errFuture Science OA
IF2.1
err2025-12-31
err0
PREAI
errWu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.
errShare
errSave
A Response to the Letter to the Editor: “Comparable or Indeterminate? A Critical Appraisal of Efficacy Claims in the MARIPOSA Exploratory Analysis”
errJournal of Thoracic Oncology
IF20.8
err2025-12-03
err0
PREAI
errSe-Hoon Lee; Shun Lu; John Xie; Sujay Shah; Seema Sethi; Byoung Chul Cho
errShare
errSave
Waste-to-Health Revolution: Upcycling Silk Sericin Byproducts into Circular Biomaterials for Biomedical Engineering
errBIOMACROMOLECULES
IF5.4
err2025-12-01
err0
PREAI
errXia, Shicheng; Yang, Jing; Wang, Zhaoyang; Lu, Shun; Wen, Shanshan; Guo, Kaiyu; Yang, Lei
errShare
errSave
Entrectinib in Asian patients with ROS1 fusion-positive non-small cell lung cancer: updated efficacy and safety analysis
errLung Cancer
IF4.4
err2025-11-21
err0
PREAI
errShun Lu; Yun Fan; Xiaorong Dong; Yan Yu; Juan Li; Jun Zhao; Chia-Chi Lin; Pengcheng Zhang; Yanjun Shi; Rui Luo; Xichun Hu
errShare
errSave
Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer
errLung Cancer
IF4.4
err2025-11-01
err0
errOAAI
errGuang-Ling Jie; Jia-Xin Zhong; Jing-Ze Wang; Zheng-Qi Cao; Xiao-Min Niu; Li-Liang Xia; Shun Lu
errShare
errSave
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-09-30
err0
PREAI
errLu, Shun; Yu, Yongfeng; Zhou, Jianya; Li, Xingya; Goto, Koichi; Min, Xuhong; Nishino, Kazumi; Cui, Jiuwei; Wu, Ling; Sakakibara, Jun; Shu, Yongqian; Dong, Xiaorong; Li, Lu; Yoneshima, Yasuto; Zhou, Chengzhi; Li, Xiaoling; Zhang, Yiping; Huang, Dingzhi; Zang, Aimin; Zhang, Wei; Wang, Xiuwen; Zhang, Li; Bai, Chong; Fang, Jian; Cao, Lejie; Zhao, Yanqiu; Yu, Yan; Shi, Meiqi; Zhong, Diansheng; Li, Fugen; Duanmu, Wenhao; Wang, Yibin
errShare
errSave
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
errThe Lancet Respiratory Medicine
IF0
err2025-09-19
err0
PREAI
errShun Lu; Oleksandr Vynnychenko; Yaroslav Kulyaba; Vladimer Kuchava; Aishah Ibrahim; Fedor Moiseenko; Cagatay Arslan; Duong Thanh Nguyen; Marina Petrovic; Irfan Cicin; Khatuna Bibichadze; Timucin Cil; Jianhua Shi; Omer Fatih Olmez; Miranda Gogishvili; Mehmet Artac; Hoang Gia Nguyen; Mark Cornfeld; Chuan Tian; Mihaela C Munteanu; Claudia V M Sette; Igor Bondarenko
errShare
errSave
First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial
errOncology and Therapy
IF3.2
err2025-09-14
err0
errOAAI
errShun Lu; Jie Wang; Yan Yu; Xinmin Yu; Yanping Hu; Liao Wangjun; Xingya Li; Yuepeng Liu; Weidong Li; Xiaofei Qu; Yuanyuan Bao; Mengzhao Wang
errShare
errSave
Single-cell RNA-seq reveals a repair pattern in cystic lesions in steroid induced osteonecrosis of the femoral head
errFrontiers in Immunology
IF5.9
err2025-09-01
err0
errOAAI
errPeng Peng†; Jiaqing Tian†; Kun Lin†; Weihua Fang; Fangming Yao; Xiaoqiang Yang; Wenyuan Hou; Fangjun Xiao; Shun Lu; Wei He; Mincong He; Huan Xiao; Qiushi Wei
errShare
errSave
Chinese expert consensus on perioperative management of patients with operable anaplastic lymphoma kinase-fusion positive non–small-cell lung cancer
errLung Cancer
IF4.4
err2025-08-21
err0
PREAI
errHai-Yan Tu; Chun Chen; Chang Chen; Chao Cheng; Ying Cheng; Junke Fu; Feng Jiang; Gaofeng Li; Yongde Liao; Jiwei Liu; Shun Lu; Wei-Min Mao; Pingping Song; Yong Song; Qun Wang; Fan Yang; Yi Yang; Jianming Ying; Jun Zhao; Wen-Zhao Zhong; Yi-Long Wu
errShare
errSave

Research Directions

肺癌的靶向治疗与免疫治疗
Co-authors
Cooperation Journals
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
R
Roy S. Herbst
H-index: 134 · Papers: 1.3K
T
Tony Mok
H-index: 131 · Papers: 1.1K
E
Enriqueta Felip
H-index: 129 · Papers: 1.5K
View more